MOTS-C (10mg Vial)
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) involved in metabolic regulation, primarily via AMPK activation.
Preclinical (non-human) research suggests MOTS-c may:
- Improve insulin sensitivity
- Increase fat oxidation
- Enhance exercise capacity
- Counter age-related metabolic decline
No completed human clinical trials exist to date. All dose discussions are extrapolated from non-human preclinical data and presented strictly for educational and scientific reference.
Educational Reconstitution Reference
- Vial content: 10 mg MOTS-c
- Diluent: 2.0 mL bacteriostatic water (BAC water)
- Add BAC water slowly to the vial using sterile technique
- Allow vial to rest ~20 minutes until fully dissolved
- Do not shake aggressively
“Reconstitution” is a fancy word that just means:
Mixing powder with water so it becomes liquid
In research settings:
- Scientists add special clean water (BACwater) to the vial
- The powder slowly melts into the water
- They wait a bit so it mixes evenly
After reconstitution:
- Total concentration:
10 mg / 2.0 mL = 5 mg/mL
(or 5,000 mcg per mL)
U-100 Syringe Concentration Math (Educational)
A U-100 insulin syringe measures 100 units = 1.0 mL
With this dilution:
- 1 unit = 0.01 mL
- Each unit = 50 mcg MOTS-c
Typical Preclinical Research Range (Contextual)
- 200–1,000 mcg once daily
- Often referenced with gradual titration over several weeks
- Derived solely from non-human models
Quick Recap